Pathogenesis of polycythemia vera: do we have the right pieces to the puzzle?

A randomized study of pomalidomide vs placebo in persons with myeloproliferative neoplasm-associated myelofibrosis and RBC-transfusion dependence.

Leukemia·2016

Which patients with myelofibrosis should receive ruxolitinib therapy? ELN-SIE evidence-based recommendations.

Leukemia·2016

Myeloproliferative neoplasms and inflammation: whether to target the malignant clone or the inflammatory process or both.

Leukemia·2016

Differential clinical effects of different mutation subtypes in CALR-mutant myeloproliferative neoplasms.

Leukemia·2015

Indication and management of allogeneic stem cell transplantation in primary myelofibrosis: a consensus process by an EBMT/ELN international working group.

Leukemia·2015

Clinical end points for drug treatment trials in BCR-ABL1-negative classic myeloproliferative neoplasms: consensus statements from European LeukemiaNET (ELN) and Internation Working Group-Myeloproliferative Neoplasms Research and Treatment (IWG-MRT).

Leukemia·2014

Prognostic significance of monotypic plasma cell infiltration of the bone marrow in patients with Waldenström macroglobulinemia.

Haematologica·2026

Impact of maintenance therapy on survival after autologous stem cell transplant for multiple myeloma regardless of response: a global analysis.

Haematologica·2026

Protecting sickle cell care during Ebola outbreaks.

Haematologica·2026

Epstein-Barr virus reactivation and post-transplant lymphoproliferative disease risk deserve a place in the JAK inhibitor toxicity profile. Comment on: "Janus kinase inhibitors as an evolving treatment for lymphomas and immune-mediated complications".

Haematologica·2026

T-cell lymphoma following chimeric antigen receptor-T therapy: a cause for concern?

Haematologica·2026

Epidemiology of respiratory viral infections among hematopoietic cellular therapy and chimeric antigen receptor T-cell therapy recipients in the post COVID-19 era.

Haematologica·2026

Aphid Probing and Phloem Feeding Trigger Distinct Plant Immune Programs, Identifying a Broad‑Spectrum Trypsin Protease Inhibitor.

Plant, cell & environment·2026

Revealing the Key Genetic Basis of Late Leaf Spot Resistance in Peanut by Combining QTL Mapping, QTL-seq and RNA-seq.

Plant, cell & environment·2026

Nor-seco-tremulane sesquiterpenoids from the endophyte fungus of Rhododendron capitatum: dual aphicidal and nematicidal activity with multi-target toxic mechanisms.

Pest management science·2026

Plant-based Dietary Patterns and the Risk of Metabolic Dysfunction-Associated Steatotic Liver Disease and Liver Cancer: A Systematic Review and Meta-analysis.

Journal of clinical and experimental hepatology·2026

Detection of tobacco seedlings in plastic-mulched fields using vegetation indices and YOLOv11.

Frontiers in plant science·2026

Bark beetle (Ips typographus) protein elicitors trigger temporally structured immune responses in Norway spruce (Picea abies) seedlings.

Frontiers in plant science·2026

Related Experiment Videos

Pathogenesis of polycythemia vera: do we have the right pieces to the puzzle?

Related Concept Videos

A randomized study of pomalidomide vs placebo in persons with myeloproliferative neoplasm-associated myelofibrosis and RBC-transfusion dependence.

Which patients with myelofibrosis should receive ruxolitinib therapy? ELN-SIE evidence-based recommendations.

Myeloproliferative neoplasms and inflammation: whether to target the malignant clone or the inflammatory process or both.

Differential clinical effects of different mutation subtypes in CALR-mutant myeloproliferative neoplasms.

Indication and management of allogeneic stem cell transplantation in primary myelofibrosis: a consensus process by an EBMT/ELN international working group.

Clinical end points for drug treatment trials in BCR-ABL1-negative classic myeloproliferative neoplasms: consensus statements from European LeukemiaNET (ELN) and Internation Working Group-Myeloproliferative Neoplasms Research and Treatment (IWG-MRT).

Prognostic significance of monotypic plasma cell infiltration of the bone marrow in patients with Waldenström macroglobulinemia.

Impact of maintenance therapy on survival after autologous stem cell transplant for multiple myeloma regardless of response: a global analysis.

Protecting sickle cell care during Ebola outbreaks.

Epstein-Barr virus reactivation and post-transplant lymphoproliferative disease risk deserve a place in the JAK inhibitor toxicity profile. Comment on: "Janus kinase inhibitors as an evolving treatment for lymphomas and immune-mediated complications".

T-cell lymphoma following chimeric antigen receptor-T therapy: a cause for concern?

Epidemiology of respiratory viral infections among hematopoietic cellular therapy and chimeric antigen receptor T-cell therapy recipients in the post COVID-19 era.

Aphid Probing and Phloem Feeding Trigger Distinct Plant Immune Programs, Identifying a Broad‑Spectrum Trypsin Protease Inhibitor.

Revealing the Key Genetic Basis of Late Leaf Spot Resistance in Peanut by Combining QTL Mapping, QTL-seq and RNA-seq.

Nor-seco-tremulane sesquiterpenoids from the endophyte fungus of Rhododendron capitatum: dual aphicidal and nematicidal activity with multi-target toxic mechanisms.

Plant-based Dietary Patterns and the Risk of Metabolic Dysfunction-Associated Steatotic Liver Disease and Liver Cancer: A Systematic Review and Meta-analysis.

Detection of tobacco seedlings in plastic-mulched fields using vegetation indices and YOLOv11.

Bark beetle (Ips typographus) protein elicitors trigger temporally structured immune responses in Norway spruce (Picea abies) seedlings.

Related Experiment Videos

Pathogenesis of polycythemia vera: do we have the right pieces to the puzzle?

Related Concept Videos

Related Articles